Within the active anti-tumour immunity represented by PD-L1 upregulation in tumour and immune cells, the CD8+ T cell could still play their role when the antigen-presenting capacity is maintained by the preserved HLA-I expression. The gene discussed is CD8A; the disease is neoplasm.